Literature DB >> 23536467

Total synthesis and biological evaluation of grassypeptolide A.

Hui Liu1, Yuqing Liu, Zhuo Wang, Xiangyou Xing, Anita R Maguire, Hendrik Luesch, Hui Zhang, Zhengshuang Xu, Tao Ye.   

Abstract

Herein, we describe in full our investigations into the synthesis of grassypeptolide A (1) in 17 linear steps with an overall yield of 11.3 %. In particular, this work features the late-stage introduction of sensitive bis(thiazoline) heterocycles and 31-membered macrocyclization conducted at the sterically congested secondary amide site in superb conversion (72 % yield). Biological evaluation indicated that grassypeptolide A significantly inhibited cancer cell proliferation in a dose-dependent manner. It induced cancer cell apoptosis, which was associated with increased cleavage of poly(ADP-ribose) polymerase (PARP) and decreased expression of bcl-2 and bcl-xL. Furthermore, grassypeptolide A also caused cell cycle redistribution by increasing cells in the G1 phase and decreasing cells in the S and G2 phases. In addition, cell cycle arrest was correlated with downregulation of cyclin D and upregulation of p27 and p21.
Copyright © 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23536467     DOI: 10.1002/chem.201203667

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  10 in total

1.  Apratoxin H and apratoxin A sulfoxide from the Red Sea cyanobacterium Moorea producens.

Authors:  Christopher C Thornburg; Elise S Cowley; Justyna Sikorska; Lamiaa A Shaala; Jane E Ishmael; Diaa T A Youssef; Kerry L McPhail
Journal:  J Nat Prod       Date:  2013-09-09       Impact factor: 4.050

Review 2.  Biological targets and mechanisms of action of natural products from marine cyanobacteria.

Authors:  Lilibeth A Salvador-Reyes; Hendrik Luesch
Journal:  Nat Prod Rep       Date:  2015-03       Impact factor: 13.423

3.  A Complementary Chemical and Genomic Screening Approach for Druggable Targets in the Nrf2 Pathway and Small Molecule Inhibitors to Overcome Cancer Cell Drug Resistance.

Authors:  James H Matthews; Xiao Liang; Valerie J Paul; Hendrik Luesch
Journal:  ACS Chem Biol       Date:  2018-03-22       Impact factor: 5.100

4.  Grassypeptolides as natural inhibitors of dipeptidyl peptidase 8 and T-cell activation.

Authors:  Jason C Kwan; Yanxia Liu; Ranjala Ratnayake; Ryo Hatano; Akiko Kuribara; Chiko Morimoto; Kei Ohnuma; Valerie J Paul; Tao Ye; Hendrik Luesch
Journal:  Chembiochem       Date:  2014-03-03       Impact factor: 3.164

5.  An Enantioselective Synthesis of a MEM-Protected Aetheramide A Derivative.

Authors:  Arun K Ghosh; Kalapala Venkateswara Rao; Siddhartha Akasapu
Journal:  Tetrahedron Lett       Date:  2014-09-10       Impact factor: 2.415

6.  Studies toward the total synthesis of Itralamide B and biological evaluation of its structural analogs.

Authors:  Xiaoji Wang; Chanshan Lv; Junmin Feng; Linjun Tang; Zhuo Wang; Yuqing Liu; Yi Meng; Tao Ye; Zhengshuang Xu
Journal:  Mar Drugs       Date:  2015-04-13       Impact factor: 5.118

Review 7.  Bioactive Compounds Isolated from Microalgae in Chronic Inflammation and Cancer.

Authors:  Elena Talero; Sofía García-Mauriño; Javier Ávila-Román; Azahara Rodríguez-Luna; Antonio Alcaide; Virginia Motilva
Journal:  Mar Drugs       Date:  2015-09-30       Impact factor: 5.118

Review 8.  New Peptides Isolated from Marine Cyanobacteria, an Overview over the Past Decade.

Authors:  Yue Mi; Jinrong Zhang; Shan He; Xiaojun Yan
Journal:  Mar Drugs       Date:  2017-05-05       Impact factor: 5.118

9.  Total Synthesis and Stereochemical Assignment of Nostosin B.

Authors:  Xiaoji Wang; Junmin Feng; Zhengshuang Xu; Tao Ye; Yi Meng; Zhiyu Zhang
Journal:  Mar Drugs       Date:  2017-02-27       Impact factor: 5.118

10.  Total Synthesis of the Cyclic Depsipeptide Vioprolide D via its (Z)-Diastereoisomer.

Authors:  Hanusch A Grab; Volker C Kirsch; Stephan A Sieber; Thorsten Bach
Journal:  Angew Chem Int Ed Engl       Date:  2020-04-20       Impact factor: 15.336

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.